|
Peregrine Pharmaceuticals, Inc.
(NASDAQ: PPHM)
Peregrine Pharmaceuticals is a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and infectious diseases.
|
Advancing Pipeline 
Peregrine is advancing first-in-class monoclonal antibodies.
Read more...
|
Upcoming Event
BIO CEO & Investor Conference
February 14, 2012
Read more...
|
Biomanufacturing 
Our subsidiary Avid Bioservices provides a comprehensive range of biomanufacturing services.
Read more...
|
Recent Data Presentation
2011 Chemical and Biological Defense Science and Technology Conference:
Phosphatidylserine as a Therapeutic Target for the Treatment of Francisella Tularensis and Yersinia Pestis Infections
View Poster...
|
Patients/Physicians 
Learn about our clinical trials
Read more...
|
Corporate Fact Sheet 
Click to download our Corporate Fact Sheet
300k PDF Download
|
| 2011 Annual Report
Download our 2011 Annual Report to shareholders
Download...
|
Job Seekers
Experienced professionals can choose from current openings posted on our job list.
View current openings...
|
|
